About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Liver Disease Clinical Trials | 200 Studies Recruiting

Clinical TrialsLiver Disease

Liver Disease Clinical Trials

Browse 200 clinical trials for liver disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 200 trials

RecruitingEuropean Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists…NCT04190849·Maastricht and 2 others CompletedThe Role of Immune Semaphorins in NAFLDTo goal is to identify semaphorins that are associated with NAFLD and to investigate their relationship with variable degrees of steatosis and fibrosis.NCT04573543·Zagreb CompletedSafety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without CirrhosisThe purpose of this study is to evaluate the effects of solithromycin on hepatic histology and biomarkers in patients with nonalcoholic steatohepatitis.NCT02510599·Cleveland, Ohio CompletedNon-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced FibrosisNon-alcoholic fatty liver disease (NAFLD) is defined as accumulation of fat in the liver which is not related to either alcohol excess or other causes such viral infection…NCT05485714·Al Ain City, Abu Dhabi Emirate

Related Searches

cirrhosistrials nafldtrials

Data from ClinicalTrials.govTerms

CompletedPrebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease (NAFLD) is a condition where accumulation of fat in the liver leads to metabolic dysfunction.NCT02568605·Calgary, Alberta

TerminatedMild Hypothermia and Acute Kidney Injury in Liver TransplantationAcute kidney injury (AKI), or worsening kidney function, is a common complication after liver transplantation (20-90% in published studies).NCT03534141·San Francisco, California and 2 others

RecruitingAn Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic SteatosisHepatic steatosis may cause inflammation and fibrosis within the liver potentially leading to end-stage liver disease cirrhosis, liver failure and death.NCT05335603·Hvidovre

TerminatedSafety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)The primary objective of this study is to evaluate whether SIM (formerly referred to as GS-6624) is effective at preventing the histologic progression of liver fibrosis and the…NCT01672866·Phoenix, Arizona and 67 others

CompletedStudy of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver FibrosisThe purpose of this study was to assess the safety, tolerability, and efficacy of a combination treatment of tropifexor (LJN452) and cenicriviroc (CVC) in adult patients with…NCT03517540·Chandler, Arizona and 64 others

UnknownEndoscopic Bariatric Therapy in NASH CirrhosisNon-alcoholic steatohepatitis (NASH) is a growing public health problem that affects more than 5% of the population and can lead to cirrhosis and hepatocellular carcinoma.NCT04281303

CompletedEmricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal HypertensionThis is a multicenter, randomized, double-blind, placebo-controlled trial involving subjects with NASH cirrhosis and severe portal hypertension (defined as HVPG ≥12 mmHg as…NCT02960204·Pasadena, California and 36 others

RecruitingThe European NAFLD RegistryThe European NAFLD Registry is a prospectively recruited, observational study supporting the study of the clinical phenotype, natural history, disease outcomes and pathophysiology…NCT04442334·Antwerp and 36 others

TerminatedA Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisEndothelin is a human hormone which has been associated with increased portal pressure in patients with liver cirrhosis (also called portal hypertension).NCT03827200·Barcelona, Catalonia and 5 others

Enrolling by invitationReducing Non-Alcoholic SteatohepatitisThe goal of this clinical trial is to learn if empagliflozin works to treat non-alcoholic steatohepatitis in adults.NCT06519448·Prague

RecruitingA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHThe purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction…NCT06920043·Chandler, Arizona and 29 others

UnknownNon-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisIn a retrospective study, 200 patients with non-alcoholic fatty liver disease, fatty liver hepatitis, and fatty liver fibrosis have been identified for pathological diagnosis of…NCT03842748·Beijing, Beijing Municipality

CompletedObeSity Related Colorectal Adenoma RiskIn the UK, around 1 in 16 men and 1 in 20 women will develop bowel cancer at some point in their lives.NCT03663062·Bolton, Greater Manchaster and 11 others

CompletedClinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.The primary objective of this study is to assess the clinical performance of LIVERFAStTM In Vitro Diagnostic (IVD) Tests (Fibrosis score, Activity score and Steatosis score) in…NCT04579874·Detroit, Michigan and 7 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver DiseaseThe purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-963272 compared to placebo in participants with nonalcoholic fatty liver disease (NAFLD)…NCT04766476·Cullman, Alabama and 18 others

RecruitingScreening At-risk Populations for Hepatic Fibrosis With Non-invasive MarkersProspective screening study at Odense University Hospital to assess the effect of transient elastography and other serum and imaging markers of liver fibrosis to detect advanced…NCT03308916·Odense

PreviousPage 7 of 10Next